ESPR R&D Expenses
Esperion Therapeutics Inc · R&D Expenses
ESPR R&D Expenses
Latest reported$44.28Mperiod ending
ESPR R&D Expenses ($8.48M → $44.28M)
Annual R&D Expenses
High-resolution chart · PNG
ESPR r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 47,852,000 | |
| 46,238,000 | |
| 86,107,000 | |
| 118,927,000 | |
| 105,975,000 | |
| 146,936,000 | |
| 175,611,000 | |
| 171,488,000 | |
| 147,603,000 | |
| 57,868,000 | |
| 29,802,000 | |
| 25,302,000 | |
| 16,014,205 | |
| 7,998,128 | |
| 7,807,702 | |
| 21,991,000 | |
| 21,454,000 | |
| 21,789,000 | |
| 8,484,125 |